Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Local Drug Makers Urge Bangladesh To Slow Allowing Newcomer Makers

This article was originally published in PharmAsia News

Executive Summary

Bangladesh's pharmaceutical industry reports as many as 20 new companies have been registered to operate in the country in recent years, possibly attracting more than $146 million in investments, according to some estimates. Industry leaders note, however, the local drug market would not be able to absorb that much investment. The same leaders said any companies that entered the market within the past five years would not reach a healthy position soon. They urged the government to concentrate less on registering newcomers and focus on ensuring drug quality. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069919

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel